Clinical Trial Update: Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 study update for APH-1105 in patients with mild to moderate Alzheimer's disease (Alzheimer's disease).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• APH-1105 (APH-1105)

Snippet

Sponsor: Aphios | Conditions: Dementia, Alzheimer Disease 1 | Phase 2 | Status: UNKNOWN